Live Breaking News & Updates on Institutional Trading Of Alnylam Pharmaceuticals

Stay updated with breaking news from Institutional trading of alnylam pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $216.19 Average PT from Analysts

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been given an average recommendation of “Moderate Buy” by the seventeen research firms that are presently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […] ....

United States , Amyw Schulman , Wolfe Research , Plato Investment Management Ltd , Alnylam Pharmaceuticals Price Performance , Alnylam Pharmaceuticals Inc , Cantor Fitzgerald , Wells Fargo Company , Cetera Advisors , Analyst Recommendations For Alnylam Pharmaceuticals , Institutional Trading Of Alnylam Pharmaceuticals , Alnylam Pharmaceuticals , Burney Co , News Ratings For Alnylam Pharmaceuticals Daily , Securities Exchange Commission , Insider Transactions At Alnylam Pharmaceuticals , Get Free Report , Director Amy , Exchange Commission , Retirement System , Investment Management Ltd , Get Free , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Given Average Recommendation of "Moderate Buy" by Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the company, Marketbeat.com reports. Seven equities research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1 […] ....

New Zealand General , New Zealand , Amyw Schulman , William Blair , Capital Research Global Investors , Alnylam Pharmaceuticals Stock Down , News Ratings For Alnylam Pharmaceuticals Daily , Norges Bank , Alnylam Pharmaceuticals , Institutional Trading Of Alnylam Pharmaceuticals , Wellington Management Group , Analyst Recommendations For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Capital International Investors , Vanguard Group Inc , Insider Activity At Alnylam Pharmaceuticals , Royal Bank , Get Free Report , Chardan Capital , Director Amy , International Investors , Management Group , Research Global Investors , Pharmaceuticals Stock Down , Get Free , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives $215.88 Consensus PT from Brokerages

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen ratings firms that are currently covering the stock, Marketbeat reports. Seven investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 1 year […] ....

Morgan Stanley , Alnylam Pharmaceuticals Stock Performance , Institutional Trading Of Alnylam Pharmaceuticals , Investment Management , Wolfe Research , Alnylam Pharmaceuticals , Quent Capital , Analyst Recommendations For Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Allspring Global Investments Holdings , News Ratings For Alnylam Pharmaceuticals Daily , Wells Fargo Company , Cantor Fitzgerald , Get Free Report , Global Investments Holdings , Get Free , Alnylam Pharmaceuticals Daily , Nasdaq Alny ,

Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50

Alnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

News Ratings For Alnylam Pharmaceuticals Daily , Vanguard Group Inc , Royal Bank , Asset Management One Co , Alnylam Pharmaceuticals Company Profile , China Universal Asset Management Co , Goldman Sachs Group , Wells Fargo Company , Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Inc , Wolfe Research , Institutional Trading Of Alnylam Pharmaceuticals , Alnylam Pharmaceuticals Trading Down , Get Free Report , Pharmaceuticals Trading Down , Universal Asset Management , Asset Management One , Management One , Alnylam Pharmaceuticals Daily ,

Alnylam Pharmaceuticals (NASDAQ:ALNY) Upgraded by StockNews.com to "Buy"

StockNews.com upgraded shares of Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) from a hold rating to a buy rating in a report issued on Friday morning. A number of other research firms have also issued reports on ALNY. Morgan Stanley reduced their price target on shares of Alnylam Pharmaceuticals from $184.00 to $176.00 and set an […] ....

New Zealand General , New Zealand , Michaelw Bonney , News Ratings For Alnylam Pharmaceuticals Daily , Wells Fargo Company , Alnylam Pharmaceuticals Stock Down , Capital International Investors , Royal Bank , Norges Bank , Needham Company , Vanguard Group Inc , Analyst Recommendations For Alnylam Pharmaceuticals , Securities Exchange Commission , Alnylam Pharmaceuticals Inc , Alnylam Pharmaceuticals , Morgan Stanley , Wellington Management Group , Institutional Trading Of Alnylam Pharmaceuticals , Free Report , Moderate Buy , Pharmaceuticals Stock Down , Get Free Report , Director Michael , Exchange Commission , International Investors , Management Group ,